These cancer patients write their own story
They hurt. They weep. They fly. They soar above the thunderheads. They plunge back to earth. They hold fast to their lovers and their children. They bruise. They burn. They heal. Cancer is not a...
Category: translational research
Ten imaginative ideas for fighting cancer funded by the Kuni Foundation
Bring cancer screening to underserved places with simplified tests that don’t require a doctor. Disrupt the niche of cancer stem cells so they can’t regenerate tumors. Defeat brain tumors by...
A surgeon-scientist blazes a new path to immune-based cancer treatment
It’s a paradox: The immune system’s cancer-fighting T cells target and infiltrate tumors, but often they stop working and let the cancer grow. Trained as a surgeon, Robert Eil, M.D., had...
Chemistry researchers identify promising next-generation cancer treatment
Drugs known as PARP-1 inhibitors have emerged as an important but limited treatment option for certain cancers. Now scientists at Oregon Health & Science University have uncovered a new class of...
A better roadmap for beating a deadly leukemia
Acute myeloid leukemia, or AML, is the most common acute blood cancer in adults — and one of the most difficult to treat. Scientists at Oregon Health & Science University have discovered a...
New approach finds drug combinations to stop cancer
In the future, the most effective cancer drug therapies will likely be combinations that not only target cancer cells but also drive cancer-suppressing responses in non-cancer cells in and around...
Treatment advance for an incurable blood cancer
Researchers are reporting an impressive advance in the treatment of mantle cell lymphoma, a type of blood cancer that is considered incurable. Patients who took the drug ibrutinib in addition to a...
Progress in preventing kidney cancer recurrence
Cancer “adjuvant” therapies are treatments designed to reduce the chances of tumors coming back after surgery. But for decades, attempts to find adjuvant treatments for kidney cancer failed to...
Clinical trial elevates new target for fighting cancers
Researchers have verified a much-needed new target for treating cancers that often become resistant to existing therapies and become deadly. In an early-phase clinical trial, the researchers tested...
How to make more cancers vulnerable to immunotherapies
Cancer immunotherapies called checkpoint inhibitors can bring dramatic, life-saving results – but only for a limited fraction of patients. Aiming to help more patients benefit, researchers in...
Targeted ‘radioligand’ improves survival in advanced prostate cancer
Cancer researchers say they have established a new, life-extending treatment option for men with prostate cancer that has spread and become resistant to hormone therapy. The injected treatment...